A
ALX Oncology Holdings Inc.
ALXO · NASDAQ · Healthcare · 264M
Closing price
$1.25
+5.93% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.6×
Enterprise value / EBITDAEV/EBITDA
-0.6×
Free cash flow yieldFCF yield
-125.8%
Return on equityROE
-391.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.1×
Interest coverage
-64.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.